FluoTag®-Q anti-SARS-CoV-2 Spike protein S1Cat no: N3501
€ 110.00 EUR
This anti-SARS-CoV-2 Spike protein S1 nanobody was developed by the team of Alejandro Rojas-Fernandez at the Institute of Medicine from the Universidad Austral de Chile. We acquired the exclusive license to produce this nanobody and make it available for research and development purposes. The FluoTag-Q anti-SARS-CoV-2 Spike protein S1 is based on the W25 clone, which has a sub-nanomolar affinity for the SARS-CoV-2 S1 protein receptor binding domain (RBD) and can neutralize infections as it efficiently competes with ACE-2 receptor binding.
Specificity: RBD of S1 protein from SARS-CoV-2
Produced in: E. coli
Concentration: 5 µM protein, 5 µM fluorophore
Recommended dilution for IF/ ICC: 1:500
Refefence: Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody